OptiNose(OPTN) - 2023 Q4 - Earnings Call Presentation

Building a Leading ENT / Allergy Specialty Company C o r p o rate P re s e ntat io n M a rc h 7 , 2 0 2 4 Forward-Looking Statements This presentation and our accompanying remarks contain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statements for this purpose and include, among others, statements relating to: the generation of XHANCE prescriptions and net re ...